• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Skylar Jeremias

home / authors / skylar-jeremias

Skylar is an associate editor for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®, and joined AJMC® in 2020. She is responsible for covering all aspects of the ever-changing global biosimilar industry and produces content that is accessible and informative for all health care stakeholders.

She has a BA in journalism and media studies from Rutgers University. You can connect with Skylar on LinkedIn.

Articles

What Are the Barriers to Biosimilar Uptake in the US?

What Are the Barriers to Biosimilar Uptake in the US?

March 27th 2020

An expert panel discussed the systemic and policy barriers to the uptake of biosimilars.

New Meta-analysis Finds Increased Risk of Certain Cancers Among Patients With Psoriasis

New Meta-analysis Finds Increased Risk of Certain Cancers Among Patients With Psoriasis

February 19th 2020

The results are in line with earlier studies, and the current review found a link with bladder cancer and lung cancer.

Study: Inconsistency of Rare Disease Definitions Causes Problems That Standardization Could Fix

Study: Inconsistency of Rare Disease Definitions Causes Problems That Standardization Could Fix

February 19th 2020

Investigators say that inconsistencies in the way rare diseases are defined contribute to misdiagnoses, delayed treatment, and other ills that could be addressed with global standards.

<1
...
1516171819
© 2024 MJH Life Sciences
AJMC®
All rights reserved.